Sunho Biologics Shareholders Unanimously Back Resolutions

Sunho Biologics,Inc. (HK:2898) has released an update.

Sunho Biologics, Inc. successfully conducted its Annual General Meeting on June 28, 2024, where all proposed resolutions were unanimously passed by the shareholders. This included the re-election of all board members and the granting of mandates for share allocation and repurchase. The meeting signifies strong shareholder confidence and the continuity of the company’s leadership and strategic initiatives.

For further insights into HK:2898 stock, check out TipRanks’ Stock Analysis page.